Management of diabetes mellitus in patients with chronic kidney disease
| Autor: | Allison J. Hahr, Mark E. Molitch |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
business.industry Diabetes Review Article General Medicine Disease medicine.disease Nephropathy Glycemic control Hemoglobin A1c Chronic kidney disease Diabetes mellitus medicine In patient Dosing Diabetic kidney disease Intensive care medicine Adverse effect business Kidney disease Glycemic |
| Zdroj: | Clinical Diabetes and Endocrinology |
| ISSN: | 2055-8260 |
| DOI: | 10.1186/s40842-015-0001-9 |
| Popis: | Glycemic control is essential to delay or prevent the onset of diabetic kidney disease. There are a number of glucose-lowering medications available but only a fraction of them can be used safely in chronic kidney disease and many of them need an adjustment in dosing. The ideal target hemoglobin A1c is approximately 7 % but this target is adjusted based on the needs of the patient. Diabetes control should be optimized for each individual patient, with measures to reduce diabetes-related complications and minimize adverse events. Overall care of diabetes necessitates attention to multiple aspects, including reducing the risk of cardiovascular disease, and often, multidisciplinary care is needed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|